I don't think an ICI is mentioned in the protocol
Post# of 157598
Quote:
Participants will be randomized 1:1 to each arm, where approximately 30 participants will receive 350 mg of leronlimab + trifluridine and tipiracil + bevacizumab and approximately 30 will receive 700 mg of leronlimab + trifluridine and tipiracil + bevacizumab.
So the ICI is after the 48 weeks, unfortunately.

